135 related articles for article (PubMed ID: 10675582)
1. The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.
Sharrack B; Hughes RA; Morris RW; Soudain S; Wade-Jones O; Barnes D; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi HA; Farmer S; Frankel JP
J Neurol Sci; 2000 Feb; 173(1):73-7. PubMed ID: 10675582
[TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Le Page E; Veillard D; Laplaud DA; Hamonic S; Wardi R; Lebrun C; Zagnoli F; Wiertlewski S; Deburghgraeve V; Coustans M; Edan G; ;
Lancet; 2015 Sep; 386(9997):974-81. PubMed ID: 26135706
[TBL] [Abstract][Full Text] [Related]
3. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Burton JM; O'Connor PW; Hohol M; Beyene J
Cochrane Database Syst Rev; 2009 Jul; (3):CD006921. PubMed ID: 19588409
[TBL] [Abstract][Full Text] [Related]
4. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
[TBL] [Abstract][Full Text] [Related]
5. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
[TBL] [Abstract][Full Text] [Related]
6. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
[TBL] [Abstract][Full Text] [Related]
7. Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial.
Ozakbas S; Cinar BP; Kosehasanoğullari G; Kahraman T; Oz D; Kursun BB
Clin Neurol Neurosurg; 2017 Sep; 160():69-72. PubMed ID: 28689102
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial.
Hervás-García JV; Ramió-Torrentà L; Brieva-Ruiz L; Batllé-Nadal J; Moral E; Blanco Y; Cano-Orgaz A; Presas-Rodríguez S; Torres F; Capellades J; Ramo-Tello C
Eur J Neurol; 2019 Mar; 26(3):525-532. PubMed ID: 30351511
[TBL] [Abstract][Full Text] [Related]
10. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G
Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
[TBL] [Abstract][Full Text] [Related]
14. Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies.
Giovannoni G; Gold R; Fox RJ; Kappos L; Kita M; Yang M; Sarda SP; Zhang R; Viglietta V; Havrdova E
Clin Ther; 2015 Nov; 37(11):2543-51. PubMed ID: 26526385
[TBL] [Abstract][Full Text] [Related]
15. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F; Kümpfel T; Schumann E; Held U; Schwan M; Blazevic M; Wismüller A; Holsboer F; Yassouridis A; Uhr M; Weber F; Daumer M; Trenkwalder C; Auer DP
BMC Neurol; 2006 May; 6():19. PubMed ID: 16719908
[TBL] [Abstract][Full Text] [Related]
16. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse.
Li XL; Zhang ZC; Zhang B; Jiang H; Yu CM; Zhang WJ; Yan X; Wang MX
Int Immunopharmacol; 2014 Dec; 23(2):546-9. PubMed ID: 25448497
[TBL] [Abstract][Full Text] [Related]
18. Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Hoogervorst EL; Polman CH; Barkhof F
Mult Scler; 2002 Oct; 8(5):415-9. PubMed ID: 12356209
[TBL] [Abstract][Full Text] [Related]
19. IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.
Sorensen PS; Haas J; Sellebjerg F; Olsson T; Ravnborg M;
Neurology; 2004 Dec; 63(11):2028-33. PubMed ID: 15596745
[TBL] [Abstract][Full Text] [Related]
20. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
Tremlett HL; Luscombe DK; Wiles CM
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
